Skip to main content

Company

Smith & Nephew PLC

LON:SN.

Smith & Nephew develops advanced medical devices for healthcare professionals around the world

147 stories · page 2 of 8

Pharma & Biotech

Smith & Nephew has to impress in results after ringing warning bell

By Proactive 21/02/2025

Pharma & Biotech

Smith & Nephew has the potential to pop next year, says leading US investment bank

By Proactive 03/12/2024

Pharma & Biotech

Smith & Nephew shares fall 13% after it slashes revenue outlook as China headwinds emerge

By Proactive 31/10/2024

Pharma & Biotech

Smith & Nephew jumps on progress with turnaround of hip and knee arm

By Proactive 01/08/2024

Pharma & Biotech

Smith & Nephew jumps as activist Cevian's stake revealed

By Proactive 04/07/2024

Pharma & Biotech

Smith & Nephew tops FTSE after bullish sales update

By Proactive 01/05/2024

Pharma & Biotech

Smith & Nephew: Scepticism is overplayed, says leading investment bank

By Proactive 11/03/2024

Pharma & Biotech

Smith & Nephew profits meet targets, 'robust' growth expected in 2024

By Proactive 27/02/2024

Pharma & Biotech

Smith+Nephew closes acquisition of CartiHeal

By Proactive 10/01/2024

Pharma & Biotech

Smith & Nephew acquires cartilage regeneration firm

By Proactive 22/11/2023

Pharma & Biotech

Smith & Nephew’s underperformance set to change, says Goldman

By Proactive 10/11/2023

Pharma & Biotech

Smith & Nephew downgrade cycle coming to an end

By Proactive 03/11/2023

Pharma & Biotech

Smith & Nephew shares up 4.2% on FY sales upgrade

By Proactive 02/11/2023

Pharma & Biotech

Smith & Nephew raises guidance after strong first half

By Proactive 03/08/2023

Pharma & Biotech

Smith & Nephew holds guidance as revenue rises 3.8%

By Proactive 26/04/2023

Pharma & Biotech

Smith & Nephew shares worth 'buying' up £16, says leading bank

By Proactive 17/04/2023

Pharma & Biotech

Smith & Nephew concerns 'overdone', says broker

By Proactive 27/03/2023

Pharma & Biotech

Smith & Nephew should benefit from orthopaedic surgical trends in 2023 - analysts

By Proactive 14/03/2023

Pharma & Biotech

Smith & Nephew annual profits fall as margins take a hit

By Proactive 21/02/2023

Pharma & Biotech

Smith & Nephew says 'on track' to meet full-year revenue forecast

The medical products company left its trading profit margin guidance for the year unchanged at around 17.5%

By Proactive 03/11/2022